The Global Multiple Sclerosis Market 2009-2024

Title	Published	Price
Dealmaking and Industry Outlook: Neurological Disease By: Decision Resources The plethora of recent reports of new genes and pathways linked to neurological diseases shows that the underlying causes of these diseases are far from certain; as a result, therapeutic strategies in effect today may \| more...	11/2/2009	$2,250.00
CDK Inhibitors Patent Landscape 2009 By: France Innovation Scientifique et Transfer IP Overview presents a patent landscape analysis of the CDK Inhibitor field. Alterations in CDK activity have been associated in the development of viral infections, neurodegenerative dis orders such as Alzheimer’s disease and proliferative \| more... Search inside this report	10/29/2009	$1,645.00
Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion By: Datamonitor Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is \| more...	10/28/2009	$15,200.00
Antipsychotics Market Forecast By: Datamonitor Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is \| more...	10/28/2009	$15,200.00
Biomarker and Diagnostic Opportunities in Clinical Research for Neurological Diseases By: Decision Resources Introduction Biomarkers and imaging tools are enabling technologies in today’s clinical research efforts for neurological diseases. Whether to improve upon existing methods for monitoring disease progression or to discover validated measures to detect diseases earlier \| more...	10/13/2009	$2,250.00
Patent Foramen Ovale Closure Market: Clinical Trial Outcomes to Play a Key Role By: GlobalData Summary Over the last decade there has been considerable evidence gathered, relating Patent Foramen Ovales (PFO) to migraines, cryptogenic stroke and decompression sickeness. There is an increased frequency of PFO in patients suffering from migraine- a \| more...	10/12/2009	$500.00
Commercial Insight: Antidepressants - Novel mechanism offers hope in depressed market By: Datamonitor Introduction With current blockbuster brands facing generic competition, Datamonitor forecasts the antidepressant market to decline at a compound annual growth rate of -2.0% (20082018). However, an antidepressant with a novel mechanism of action has huge commercial \| more...	10/8/2009	$15,200.00
Commercial Insight: Parkinson's Disease - Japan and Europe to drive total market growth By: Datamonitor Introduction The Parkinson's disease market is approaching maturity, with the threat of generic incursion evident in each drug class. Although growth will be stifled by generic launches, relatively successful lifecycle management strategies and new product launches \| more...	10/8/2009	$15,200.00
Parkinson's Disease Market Forecast By: Datamonitor Introduction The Parkinson's disease market is approaching maturity, with the threat of generic incursion evident in each drug class. Although growth will be stifled by generic launches, relatively successful lifecycle management strategies and new product launches \| more...	10/2/2009	$15,200.00
SPECIAL REPORT: Can Innovation Supplant Convention in Sarcoidosis Treatment? By: Decision Resources Introduction “I’d love there to be a better agent,” says a thought leader on the current state of sarcoidosis treatment. Many sarcoidosis patients require little or no treatment, but patients with chronic disease need a \| more...	9/23/2009	$4,500.00

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/23/2009 - 4